Cargando…
NT Pro‐BNP can be used as a risk predictor of clinical atrial fibrillation with or without left atrial enlargement
BACKGROUND: NT Pro‐BNP is a blood marker secreted by cardiomyocytes. Myocardial stretch is the main factor to stimulate NT Pro‐BNP secretion in cardiomyocytes. NT Pro‐BNP is an important risk factor for cardiac dysfunction, stroke, and pulmonary embolism. So does atrial myocyte stretching occur when...
Autores principales: | Zhao, Xiao, Li, Hao, Liu, Cai, Ren, Yuanyuan, Sun, Chaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799051/ https://www.ncbi.nlm.nih.gov/pubmed/34952980 http://dx.doi.org/10.1002/clc.23760 |
Ejemplares similares
-
Left atrial diameter and atrial fibrillation, but not elevated NT-proBNP, predict the development of pulmonary hypertension in patients with HFpEF
por: LIU, Yi-Xian, et al.
Publicado: (2020) -
Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainide
por: Amin, Ahmad Shoaib, et al.
Publicado: (2015) -
Joint Associations of Obesity and NT‐proBNP With the Incidence of Atrial Fibrillation in the ARIC Study
por: Almuwaqqat, Zakaria, et al.
Publicado: (2019) -
Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
por: Staszewsky, Lidia, et al.
Publicado: (2021) -
NT-pro-BNP as a Predictor for Recurrence of Atrial Fibrillation after Primary Cryoballoon Pulmonary Vein Isolation
por: Blessberger, Hermann, et al.
Publicado: (2022)